Outsourcing STREAM

  1. Altasciences Has You Covered From Coast To Coast 1/30/2023

    With your success in mind, we designed an integrated early phase drug development offering with eight locations, to get you from lead candidate selection to clinical proof of concept, and beyond.

  2. How To Take Advantage Of Early Access Programs For The EU 6/12/2024

    Learn how to leverage Early Access Programs (EAPs) in the EU to expedite market entry for innovative life science products. Gain insights into running successful EAPs, including crucial steps for France.

  3. Getting Buy-In For Disclosure As A Service 6/3/2020

    Clinical trial disclosure teams often have a tough time convincing upper management on the benefits of Disclosure as a Service. Hear how two sponsors “sold” the idea of outsourcing this function. Watch the short TrialScope interview.

  4. Early Phase Clinical Development Solutions 1/30/2023

    Our experts in the design and conduct of clinical pharmacology and early efficacy studies ensure that data generated meets your objectives.

  5. Improving Sponsor Oversight Of The Trial Master File 2/15/2023

    In the face of increasing documentation requirements and trial complexity, discover how global biopharmaceutical company Chiesi and its CRO partners collaborated to ensure ongoing oversight compliance.

  6. The Path Forward, Altasciences' Approach To Project Management 3/19/2024

    Learn about a unique, integrated program management strategy that can lower your costs and reduce program timelines from lead candidate selection to clinical proof-of-concept by up to 40%.

  7. A Different Kind Of CRO 1/30/2023

    Altasciences is an award-winning, forward-thinking, mid-size early phase contract research organization, in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development.

  8. Imagine… Easier, Proactive Drug Development 2/14/2023

    Imagine partnering with a single CRO/CDMO for your early phase drug development. With Altasciences, you don’t have to imagine—learn how they’re able to deliver for your project.

  9. The Heart Of The Matter: Early Vs. Late QT Prolongation Testing 2/8/2023

    Dr. Beatrice Setnik, Altasciences' Chief Scientific Officer, walks through the differences between early and late QT prolongation testing.

  10. Flipping The Drug Development Industry On Its Head 6/18/2024

    The video dives into the obstacles of the traditional outsourcing relationship between CROs and sponsors, and how Altasciences has broken from tradition to offer an alternative model.